# Johnson & Johnson (JNJ) — Q1-2025 Earnings Results

**Report date:** 2025-04-15 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q1-2025

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Reaction N/A

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.77 | N/A | +7.91% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to shareholder value. However, they did not provide specific guidance for the upcoming quarters.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on delivering value to our shareholders.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

This earnings report indicates that Johnson & Johnson performed better than expected in terms of earnings per share. However, the lack of revenue data and guidance leaves some uncertainty about future performance. The stock reaction is not available, which may suggest limited immediate market response to the earnings announcement.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q1-2025_